Evidence map›Paper›PMID 41414966›Full record

ArticleHaematologica2026

Impact of the plasma cell quantification method on the International Myeloma Working Group diagnostic criteria for MGUS/SMM.

Atsushi Uehara, Hajime Sakuma, Fuminari Fujii, Masanori Toho, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Ryuta Matsuda, Daiki Isuge, Daisuke Ikeda and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Atsushi UeharaDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa.
Hajime SakumaDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa.
Fuminari FujiiDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa.
Masanori TohoDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa.
Rikako TabataDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa.
Kentaro NaritaDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa.
Masami TakeuchiDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa.
Ryuta MatsudaDepartment of Clinical Pathology, Kameda Medical Center, Kamogawa.
Daiki IsugeDepartment of Clinical Pathology, Kameda Medical Center, Kamogawa.
Daisuke IkedaDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan; Department of Hematology/Oncology, Okayama University Hospital, Okayama.
Toshihiro MiyamotoDepartment of Hematology, Kanazawa University, Kanazawa.
Hiroyuki TakamatsuDepartment of Hematology, Kanazawa University, Kanazawa.
Kosei MatsueDepartment of Hematology/Oncology, Kameda Medical Center, Kamogawa. koseimatsue@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41414966
PMCPMC13231083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.